razoxane has been researched along with Chromosome-Defective Micronuclei in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Allah, AR; Al-Harbi, MM; Al-Khedhairy, AA; Al-Rasheed, NM; Ashour, AE; Attia, SM; Bakheet, SA; Korashy, HM; Musarrat, J; Saquib, Q | 1 |
| Eastmond, DA; Roy, SK | 1 |
2 other study(ies) available for razoxane and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.
Topics: Animals; Apoptosis; Bone Marrow Cells; Caspase 3; Cell Cycle; Chromosomes, Mammalian; DNA Breaks; DNA Damage; Flow Cytometry; Glutathione; Lipid Peroxidation; Male; Mice; Micronuclei, Chromosome-Defective; Razoxane; Reactive Oxygen Species; Teniposide | 2011 |
Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Topics: Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Humans; In Situ Hybridization, Fluorescence; Leukemia; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mutagens; Neoplasms, Second Primary; Nondisjunction, Genetic; Polyploidy; Razoxane | 2011 |